(2R,4S)-2-methyl-4-((2-methylpropan-2-yl)oxycarbonylamino)-5-(4-phenylphenyl)pentanoic acid

HCID 46193546

Grundinformationen

CAS
1012341-50-2
Standard-SMILES
C[C@H](C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)OC(C)(C)C)C(=O)O
InChIKey
YNELJETWNMPEEH-UZLBHIALSA-N
Summenformel
C23H29NO4
Durchschnittliche Molmasse
383,5 g/mol
Monoisotopische Masse
383,20965841

Namen und Bezeichner

Bevorzugter Name
(2R,4S)-2-methyl-4-((2-methylpropan-2-yl)oxycarbonylamino)-5-(4-phenylphenyl)pentanoic acid
IUPAC
(2R,4S)-2-methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-(4-phenylphenyl)pentanoic acid
Englischer Name
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid
Summenformel
C23H29NO4
Molmasse
383.48

Namen und Synonyme

(2R,4S)-2-methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-(4-phenylphenyl)pentanoic acid(2R,4S)-2-methyl-4-((2-methylpropan-2-yl)oxycarbonylamino)-5-(4-phenylphenyl)pentanoic acidRefChem:397629695-674-11012341-50-2(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acidMFCD27955981(2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methylpentanoic acidValsartan Impurity 80FJ7AWX8DMF(2R,4S)-5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid[1,1'-Biphenyl]-4-pentanoic acid, gamma-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-methyl-, (alphaR,gammaS)-
Weitere Namen anzeigen
sacubitril intermediate(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl) amino]-2-methylpentanoic acid AHU84AHU(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid [DMF No. 031502]AHU08LCZ696-24
(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid(2R,4S)-5-(4-Biphenylyl)-4-(Boc-amino)-2-methylpentanoic Acid(2R,4S)-5-(4-Biphenylyl)-2-methyl-4-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)pentanoic acid(2R,4S)-5-((1,1'-Biphenyl)-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acidYNELJETWNMPEEH-UZLBHIALSA-N(1,1'-Biphenyl)-4-pentanoic acid, gamma-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-methyl-, (alphaR,gammaS)-(alphaR,gammaS)-gamma-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-methyl[1,1'-biphenyl]-4-pentanoic Acid;

Datenbank-Bezeichner

CAS
1012341-50-2
PubChem CID
46193546
DTXSID
DTXSID001123526
UNII
FJ7AWX8DMF
EC Number
695-674-1
Nikkaji
J3.128.635B

Eigenschaften

Berechnete Struktureigenschaften

XLogP
5
Polarare Oberfläche (TPSA)
75,6 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
9
Schwere Atome
28

Physikochemische Eigenschaften

Schmelzpunkt
145 · 145-147°C
Siedepunkt
582.6 · 582.6±50.0 °C(Predicted)
Dichte
1.115 · 1.115±0.06 g/cm3(Predicted)
storage temp.
2 · 2-8°C
Löslichkeit
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Sonicated)
Aggregatzustand
Solid

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 33.3% (1 of 3) of reports.

Warning

H302 (33.3%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationREACH registered substance: (2R,4S)-2-methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-(4-phenylphenyl)pentanoic acid (EC: 695-674-1)
Hazard Classes and CategoriesAcute Tox. 4 (33.3%)

Sicherheitsdaten

Alarmwort
Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302

Chemie und Industrie

Anwendungen · 1 Eintrag

Beschreibung(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid is a pharmaceutical intermediate compound that can be used to synthesize Sacubitril, a neprilysin inhibitor used as an adjuvant drug in combination with valsartan to reduce the risk of cardiovascular death and heart failure hospitalization in patients with chronic heart failure (NYHA class II-IV) and reduced ejection fraction.

Anbieter100 Anbieter

镇江中智化学科技有限公司0511-15050866711; 15050866711 · [email protected]
T&W GROUP021-61551611 13296011611 · [email protected]
上海同昌生物医药科技有限公司+86-21-33282107
衢州信诺医药科技有限公司0570-3856196 13615701454 · [email protected]
北京华威锐科化工有限公司0757-86329057 18934348241 · [email protected]

Zugehörige Reaktionen

82

Notizen zur Verbindung

Wird geladen…